A Phase IIb, Randomized, Open, Parallel-Group, Multi-Center Trial to Assess the Efficacy and Safety of Belotecan(CamtoBell Inj.) or Topotecan in Patients With Recurrent or Refractory Ovarian Cancer
Phase of Trial: Phase II
Latest Information Update: 29 Sep 2016
At a glance
- Drugs Belotecan (Primary) ; Topotecan
- Indications Ovarian cancer
- Focus Therapeutic Use
- 20 Sep 2016 Status changed to completed.
- 02 Jun 2015 Status changed from recruiting to active, no longer recruiting as result presented at 51st Annual Meeting of the American Society of Clinical Oncology.
- 02 Jun 2015 Results presented at the 51st Annual Meeting of the American Society of Clinical Oncology.